Dental extractions during anticoagulant therapy

Area of Science:

• Cardiovascular Medicine
• Oral Surgery
• Pharmacology

Background:

• Anticoagulant therapy, such as with Coumarin, is crucial for patients with prosthetic heart valves.
• Dental extractions pose a bleeding risk for patients on anticoagulants.
• Current guidelines often recommend discontinuing Coumarin before dental procedures, potentially increasing thrombotic risk.

Purpose of the Study:

• To evaluate the safety of performing dental extractions without discontinuing Coumarin therapy.
• To compare bleeding complications in patients continuing versus temporarily interrupting Coumarin therapy.
• To establish safe management protocols for dental extractions in anticoagulated patients.

Main Methods:

• Observational study comparing two groups of 15 patients undergoing dental extractions.
• One group continued their regular Coumarin therapy; the other temporarily interrupted it.
• Bleeding was assessed post-extraction, with Prothrombin Time (PT) monitored in the continuing group.

Main Results:

• No significant difference in bleeding was observed between the group that continued Coumarin and the group that interrupted it.
• Patients continuing Coumarin therapy maintained a therapeutic Prothrombin Time (PT) range of 20-30% during the procedure.
• Hospitalization is recommended for patients with prosthetic heart valves undergoing dental extractions, regardless of Coumarin management.

Conclusions:

• Continuing Coumarin therapy during dental extractions is a safe option, showing no increased bleeding risk.
• Dental extractions can be safely performed in patients on Coumarin within a therapeutic PT range of 20-30%.
• Hospitalization ensures optimal patient monitoring and management during dental extractions for those on anticoagulants, particularly with prosthetic heart valves.